- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AprilBio Co Ltd (397030)
The AprilBio share price today is 26,550, view KQ 397030 stock exchange data. Track the latest AprilBio share price with real-time updates on 397030 stock performance including market cap, day range, 52-week range and dividend yield. Access 397030 charts, earnings dates and analyst estimates to support your investment decisions.
KOSDAQ
Currency in KRW
26,550
+2,050(+8.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,200
27,100
52 wk Range
19,310
76,700
397030 is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,20027,100
52 wk Range
19,31076,700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
397030 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
100,000
Upside
+276.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 100,000
(+276.65% Upside)
Earnings
Latest Release
15-05-2026
EPS / Forecast
9.00 / 45.00
Revenue / Forecast
725.35M / --
Compare 397030 to Peers and Sector
Metrics to compare | 397030 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship397030PeersSector | |
|---|---|---|---|---|
P/E Ratio | −56.7x | −16.8x | −0.4x | |
PEG Ratio | 0.41 | −0.45 | 0.00 | |
Price/Book | 5.9x | 2.4x | 2.6x | |
Price / LTM Sales | 790.8x | 8.1x | 3.0x | |
Upside (Analyst Target) | 295.3% | 67.9% | 56.0% | |
Fair Value Upside | Unlock | 11.2% | 9.1% | Unlock |
AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the AprilBio (397030) Share Price Today?
The AprilBio share price today is 26,550.
What is the current AprilBio (397030) share price and day range?
As of 23-07-2026, the AprilBio share price is 26,550, with a previous close of 24,500. The share price has ranged from 24,200 to 27,100 today, while the 52-week range spans from 19,310 to 76,700.
What Is the AprilBio Market Cap?
As of today, AprilBio market cap is 573.64B.
What Is the AprilBio (397030) Share Price Target?
The average 12-month share price target for AprilBio is 1,00,000, with a high estimate of 100000 and a low estimate of 100000. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +276.65% Upside potential.
What Is AprilBio's Earnings Per Share (TTM)?
The AprilBio EPS (TTM) is -444.
From a Technical Analysis Perspective, Is 397030 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does AprilBio Trade On?
AprilBio is listed and trades on the KOSDAQ.
What Is the Stock Symbol for AprilBio?
The stock symbol for AprilBio is "397030."
How Many Times Has AprilBio Stock Split?
AprilBio has split 1 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.